Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$114,495,258
+$956,247 QoQ
Shares Held
2,683,902
+13.9% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#18
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Dec 31, 2025CallValue
$43,614
CallShares
900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $8,073,972,287 across 18 Drug Manufacturers - General names. SNY ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,143,891 | $1,372,017,294 | |
| 2 | ABBV |
AbbVie Inc.
|
5,015,515 | $1,262,104,193 | |
| 3 | AZN |
Astrazeneca PLC
|
6,592,403 | $1,250,051,454 | |
| 4 | JNJ |
Johnson & Johnson
|
4,651,595 | $1,181,365,579 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,793,897 | $873,015,763 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,113,242 | $646,006,993 | |
| 7 | AMGN |
Amgen Inc
|
1,326,673 | $480,414,824 | |
| 8 | PFE |
Pfizer Inc
|
16,746,801 | $403,262,965 |
All Filings in SNY
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $114,495,258 | 2,683,902 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $113,539,011 | 2,356,559 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $103,416,353 | 2,134,056 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $43,614 | 900 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $77,811,606 | 1,648,551 | Shares | Sole | 2026-03-31 | |
| 2025-09-30 | $4,720 | 100 | Call | Sole | 2026-03-31 | |
| 2025-06-30 | $41,000,164 | 848,689 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $29,422,415 | 530,516 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $48,853,468 | 1,012,927 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $36,870,059 | 639,772 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $14,960,025 | 308,327 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $23,398,858 | 481,458 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $10,297,540 | 207,069 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $9,987,392 | 186,193 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $6,352,869 | 117,864 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $11,112,671 | 204,202 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $13,325,174 | 275,143 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $11,973,789 | 314,934 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $17,938,904 | 358,563 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,944,144 | 135,258 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,192,380 | 23,800 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $3,231,499 | 64,501 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,045,918 | 125,408 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,822,693 | 72,592 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,650,312 | 53,585 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,341,303 | 109,926 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $13,833,372 | 275,730 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $19,074,831 | 373,650 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $319,156 | 7,300 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $7,675,744 | 175,566 | Shares | Sole | 2020-05-13 | |
| 2020-03-31 | $6,142,660 | 140,500 | Call | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||